Efficacy of budesonide/formoterol inhalation powder in treating viral pneumonia in children

doi:10.12998/wjcc.v12.i21.4469

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 21

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (716)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-5) series.

Item

Count

PDF

HTML

490

Tables (1-5)

Sum=585

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=89

Jul 26, 2024 (publication date) through Nov 2, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Clin Cases. Jul 26, 2024; 12(21): 4469-4475
Published online Jul 26, 2024. doi: 10.12998/wjcc.v12.i21.4469

Table 2 Comparison of pulmonary-function-related indicators between the two groups of pediatric viral pneumonia patients treated with different methods

Group	FVC (L)		FEVl (L)		FEVl/FVC (%)		PEF (L/min)
Group	Before	After	Before	After	Before	After	Before	After
Control group (n = 30)	2.09 ± 0.31	2.39 ± 0.39^a	1.66 ± 0.22	2.14 ± 0.37^a	54.53 ± 7.14	76.11 ± 7.49^a	254.28 ± 22.22	319.11 ± 21.63^a
Observation group (n = 30)	2.04 ± 0.41	3.10 ± 0.42^a	1.69 ± 0.31	3.08 ± 0.35^a	54.18 ± 6.55	83.59 ± 5.17^a	253.73 ± 23.75	352.50 ± 14.89^a
t	0.428	-6.801	-0.466	-10.084	0.198	-4.509	0.547	0.040
P value	0.663	< 0.001	0.643	< 0.001	0.844	< 0.001	0.927	< 0.001

^aP < 0.05 vs before treatment. FVC: Forced vital capacity; FEV1: Forced expiratory volume in 1 s; PEF: Peak expiratory flow.

Citation: Lin ZL, Xu X, Yang JJ, Lu LQ, Huang H, Hua XZ, Lu LD. Efficacy of budesonide/formoterol inhalation powder in treating viral pneumonia in children. World J Clin Cases 2024; 12(21): 4469-4475
URL: https://www.wjgnet.com/2307-8960/full/v12/i21/4469.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i21.4469